Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment

References

• Baltimore City Health Department. (2017). Neighborhood Health Profile Reports. https://health.baltimorecity.gov/neighborhoods/neighborhood-health-profile-reports
   Google Scholar
• Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C. R., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299. https://doi.org/10.1177/0269881114565144
   PubMed Web of Science ®Google Scholar
• Burke, L. (2020, June 15). Johns Hopkins says no private police, for Now. https://www.insidehighered.com/news/2020/06/15/johns-hopkins-presses-pause-private-police-force-plans
   Google Scholar
• Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Pilling, S., Curran, V. H., & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet. Psychiatry, 3(7), 619–627. https://doi.org/10.1016/S2215-0366(16)30065-7
   PubMed Web of Science ®Google Scholar
• Cell Editorial Team. (2020). Science has a racism problem. Cell, 181(7), 1443–1444. https://doi.org/10.1016/j.cell.2020.06.009
   PubMed Web of Science ®Google Scholar
• Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2020). Effects of psilocybin-assisted therapy on major depressive disorder. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2020.3285
   Google Scholar
• Dettling, L. J., Hsu, J. W., Jacobs, L., Moore, K. B., & Thompson, J. P. (2017). Recent Trends in wealth-holding by race and ethnicity: Evidence from the Survey of Consumer Finances (FEDS Notes). Board of Governors of the Federal Reserve System, https://www.federalreserve.gov/econres/notes/feds-notes/recent-trends-in-wealth-holding-by-race-and-ethnicity-evidence-from-the-survey-of-consumer-finances-20170927.htm
   Google Scholar
• Feagin, J., & Bennefield, Z. (2014). Systemic racism and U.S. health care. Social Science & Medicine (1982), 103, 7–14. https://doi.org/10.1016/j.socscimed.2013.09.006
   PubMed Web of Science ®Google Scholar
• Feuer, W. (2020, November 4). Oregon becomes first state to legalize magic mushrooms as more states ease drug laws in “psychedelic renaissance.” CNBC. https://www.cnbc.com/2020/11/04/oregon-becomes-first-state-to-legalize-magic-mushrooms-as-more-states-ease-drug-laws.html
   Google Scholar
• Garcia-Romeu, A., Barrett, F. S., Carbonaro, T. C., Johnson, M. W., & Griffith, R. R. (2021). Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Journal of Psychopharmacology. https://doi.org/10.1177/0269881121991822
   Google Scholar
• Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016). Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology, 24(4), 229–268. https://doi.org/10.1037/pha0000084
   PubMed Web of Science ®Google Scholar
• George, J. R., Michaels, T. I., Sevelius, J., & Williams, M. T. (2019). The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. Journal of Psychedelic Studies, 4(1), 4–15. https://doi.org/10.1556/2054.2019.015
   Google Scholar
• Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. https://doi.org/10.1177/0269881116675513
   PubMed Web of Science ®Google Scholar
• Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68(1), 71–78. https://doi.org/10.1001/archgenpsychiatry.2010.116
   PubMed Web of Science ®Google Scholar
• Hsieh, N., & Ruther, M. (2016). Sexual minority health and health risk factors: Intersection effects of gender, race, and sexual identity. American Journal of Preventive Medicine, 50(6), 746–755. https://doi.org/10.1016/j.amepre.2015.11.016
   PubMed Web of Science ®Google Scholar
• Jee-Lyn García, J., & Sharif, M. Z. (2015). Black lives matter: A commentary on racism and public health. American Journal of Public Health, 105(8), e27–e30. https://doi.org/10.2105/AJPH.2015.302706
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983–992. https://doi.org/10.1177/0269881114548296
   PubMed Web of Science ®Google Scholar
• LaVeist, T. A., Nuru-Jeter, A., & Jones, K. E. (2003). The association of doctor-patient race concordance with health services utilization. Journal of Public Health Policy, 24(3–4), 312–323. https://doi.org/10.2307/3343378
   PubMed Web of Science ®Google Scholar
• Marmot, M. (2017). The health gap: The challenge of an unequal world: The argument. International Journal of Epidemiology, 46(4), 1312–1318. https://doi.org/10.1093/ije/dyx163
   PubMed Web of Science ®Google Scholar
• McGinnis, J. M., Williams-Russo, P., & Knickman, J. R. (2002). The case for more active policy attention to health promotion. Health Affairs, 21(2), 78–93. https://doi.org/10.1377/hlthaff.21.2.78
   PubMed Web of Science ®Google Scholar
• Michaels, T. I., Purdon, J., Collins, A., & Williams, M. T. (2018). Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry, 18(1), 245. https://doi.org/10.1186/s12888-018-1824-6
   PubMed Web of Science ®Google Scholar
• Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2019). MDMA-assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology, 236(9), 2735–2745. https://doi.org/10.1007/s00213-019-05249-5
   PubMed Web of Science ®Google Scholar
• Mitter, S. (2018, April 18). Gentrify or die? Inside a university’s controversial plan for Baltimore. The Guardian. http://www.theguardian.com/cities/2018/apr/18/gentrify-or-die-inside-a-universitys-controversial-plan-for-baltimore
   Google Scholar
• Nazha, B., Mishra, M., Pentz, R., & Owonikoko, T. K. (2019). Enrollment of racial minorities in clinical trials: Old problem assumes new urgency in the age of immunotherapy. American Society of Clinical Oncology Educational Book, 39, 3–10. https://doi.org/10.1200/EDBK_100021
   PubMedGoogle Scholar
• Pietila, A. (2010). Not in my neighborhood: How bigotry shaped a Great American City. (Illustrated edition). Ivan R. Dee.
   Google Scholar
• Power, G. (1983). Apartheid baltimore style: The residential segregation ordinances of 1910–1913. Maryland Law Review, 42(2), 289–328.
   Google Scholar
• Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., & McDonald, W. M. (2020). Psychedelics and psychedelic-assisted psychotherapy. The American Journal of Psychiatry, 177(5), 391–410. https://doi.org/10.1176/appi.ajp.2019.19010035
   PubMed Web of Science ®Google Scholar
• Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology, 30(12), 1165–1180. https://doi.org/10.1177/0269881116675512
   PubMed Web of Science ®Google Scholar
• Sardar, M. R., Badri, M., Prince, C. T., Seltzer, J., & Kowey, P. R. (2014). Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. JAMA Internal Medicine, 174(11), 1868–1870. https://doi.org/10.1001/jamainternmed.2014.4758
   PubMed Web of Science ®Google Scholar
• Savage, C., & McCabe, O. L. (1973). Residential psychedelic (LSD) therapy for the narcotic addict. A controlled study. Archives of General Psychiatry, 28(6), 808–814. https://doi.org/10.1001/archpsyc.1973.01750360040005
   PubMed Web of Science ®Google Scholar
• Shalit, N., Rehm, J., & Lev-Ran, S. (2019). Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III. Addictive Behaviors, 89, 35–43. https://doi.org/10.1016/j.addbeh.2018.09.020
   PubMed Web of Science ®Google Scholar
• Skloot, R. (2011). The immortal life of henrietta lacks. Crown.
   Google Scholar
• Streed, C. G., McCarthy, E. P., & Haas, J. S. (2017). Association between gender minority status and self-reported physical and mental health in the United States. JAMA Internal Medicine, 177(8), 1210–1212. https://doi.org/10.1001/jamainternmed.2017.1460
   PubMed Web of Science ®Google Scholar
• Thomas, G., Lucas, P., Capler, N. R., Tupper, K. W., & Martin, G. (2013). Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews, 6(1), 30–42. https://doi.org/10.2174/15733998113099990003
   PubMedGoogle Scholar
• Williams, D. R. (2012). Miles to go before we sleep: Racial inequities in health. Journal of Health and Social Behavior, 53(3), 279–295. https://doi.org/10.1177/0022146512455804
   PubMed Web of Science ®Google Scholar
• Williams, M. T., Davis, A. K., Xin, Y., Sepeda, N. D., Grigas, P. C., Sinnott, S., & Haeny, A. M. (2020). People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. Drugs: Education, Prevention and Policy, 1–12. https://doi.org/10.1080/09687637.2020.1854688
   Web of Science ®Google Scholar
• Yockey, R. A., Vidourek, R. A., & King, K. A. (2020). Trends in LSD use among US adults: 2015–2018. Drug and Alcohol Dependence, 212, 108071. https://doi.org/10.1016/j.drugalcdep.2020.108071
   PubMed Web of Science ®Google Scholar